• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

RCPT:US

46.8300 USD 0.3800 0.82%

As of 20:10:00 ET on 08/22/2014.

Snapshot for Receptos Inc (RCPT)

Open: 46.1500 Day's Range: 45.7000 - 47.0300 Volume: 287,540
Previous Close: 46.4500 52wk Range: 15.2100 - 55.0000 1-Yr Rtn: +189.79%

Stock Chart for RCPT

No chart data available.
  • RCPT:US 46.8700
  • 1D
  • 1M
  • 1Y
46.4500
Interactive RCPT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RCPT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.7900
Est. EPS (USD) (12/2014) -4.1750
Est. PEG Ratio -
Market Cap (M USD) 1,277.46
Shares Outstanding (M) 27.28
30 Day Average Volume 349,770
Price/Book (mrq) 4.0455
Price/Sale (ttm) 211.7436
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RCPT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RCPT

Receptos, Inc. discovers and develops small molecule drug therapies. The Company specializes in the development of G protein-coupled receptors therapeutic candidates, as well as focuses on the discovery, development, and commercialization of various therapeutics for immune disorders.

Faheem HasnainPresident/CEOGraham K CooperChief Financial Officer
Marcus F BoehmChief Technology OfficerRobert J PeachChief Scientific Officer
More Company Profile & Key Executives for RCPT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil